Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $590.12 million. The enterprise value is $354.58 million.
| Market Cap | 590.12M |
| Enterprise Value | 354.58M |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 129.98 million shares outstanding. The number of shares has decreased by -0.28% in one year.
| Current Share Class | 129.98M |
| Shares Outstanding | 129.98M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 8.48% |
| Owned by Institutions (%) | 50.52% |
| Float | 102.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.85 |
| Forward PS | 2.72 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.48 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -152.08 |
Financial Efficiency
Return on equity (ROE) is -23.04% and return on invested capital (ROIC) is -52.92%.
| Return on Equity (ROE) | -23.04% |
| Return on Assets (ROA) | -6.31% |
| Return on Invested Capital (ROIC) | -52.92% |
| Return on Capital Employed (ROCE) | -13.09% |
| Weighted Average Cost of Capital (WACC) | 10.35% |
| Revenue Per Employee | $303,092 |
| Profits Per Employee | -$118,150 |
| Employee Count | 682 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.93 |
Taxes
In the past 12 months, CTKB has paid $39.76 million in taxes.
| Income Tax | 39.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.52% in the last 52 weeks. The beta is 1.19, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +15.52% |
| 50-Day Moving Average | 4.56 |
| 200-Day Moving Average | 4.60 |
| Relative Strength Index (RSI) | 47.20 |
| Average Volume (20 Days) | 702,692 |
Short Selling Information
The latest short interest is 4.99 million, so 3.84% of the outstanding shares have been sold short.
| Short Interest | 4.99M |
| Short Previous Month | 4.90M |
| Short % of Shares Out | 3.84% |
| Short % of Float | 4.85% |
| Short Ratio (days to cover) | 6.16 |
Income Statement
In the last 12 months, CTKB had revenue of $206.71 million and -$80.58 million in losses. Loss per share was -$0.63.
| Revenue | 206.71M |
| Gross Profit | 107.23M |
| Operating Income | -47.45M |
| Pretax Income | -40.82M |
| Net Income | -80.58M |
| EBITDA | -39.76M |
| EBIT | -47.45M |
| Loss Per Share | -$0.63 |
Balance Sheet
The company has $262.00 million in cash and $26.46 million in debt, with a net cash position of $235.54 million or $1.81 per share.
| Cash & Cash Equivalents | 262.00M |
| Total Debt | 26.46M |
| Net Cash | 235.54M |
| Net Cash Per Share | $1.81 |
| Equity (Book Value) | 321.95M |
| Book Value Per Share | 2.48 |
| Working Capital | 293.60M |
Cash Flow
In the last 12 months, operating cash flow was -$6.04 million and capital expenditures -$6.04 million, giving a free cash flow of -$12.08 million.
| Operating Cash Flow | -6.04M |
| Capital Expenditures | -6.04M |
| Depreciation & Amortization | 7.69M |
| Net Borrowing | 3.05M |
| Free Cash Flow | -12.08M |
| FCF Per Share | -$0.09 |
Margins
Gross margin is 51.87%, with operating and profit margins of -22.95% and -38.98%.
| Gross Margin | 51.87% |
| Operating Margin | -22.95% |
| Pretax Margin | -19.75% |
| Profit Margin | -38.98% |
| EBITDA Margin | -19.24% |
| EBIT Margin | -22.95% |
| FCF Margin | n/a |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.28% |
| Shareholder Yield | 0.28% |
| Earnings Yield | -13.65% |
| FCF Yield | -2.05% |
Analyst Forecast
The average price target for CTKB is $5.56, which is 22.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.56 |
| Price Target Difference | 22.47% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.73% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 3.15 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 3 |